Structural predictors of loss of renal function in american indians with type 2 diabetes

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2016, Pages 254-261

  Fufaa, Gudeta D ^a   Weil, E Jennifer ^a   Lemley, Kevin V ^b   Knowler, William C ^a   Brosius, Frank C ^c   Yee, Berne ^d   Mauer, Michael ^e   Nelson, Robert G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Southwest Kidney Institute   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetes mellitus, type 2; Diabetic nephropathy; Epidemiology and outcomes; Glomerular filtration rate; Humans; Indians, North American; Kidney biopsy; Kidney diseases; Renal morphology

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; IOTALAMIC ACID; LOSARTAN;

ADULT; ALBUMIN CREATININE RATIO; AMERICAN INDIAN; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; ENDOTHELIAL FENESTRATION; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; KIDNEY STRUCTURE; LOWER GLOMERULAR FILTRATION SURFACE DENSITY; MAJOR CLINICAL STUDY; MALE; MEAN GLOMERULAR VOLUME; MESANGIAL FRACTIONAL VOLUME; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPODOCYTE CELL NUMBER; PODOCYTE FOOT PROCESS WIDTH; RENAL CLEARANCE; RENAL SYSTEM PARAMETERS; URINALYSIS; BIOPSY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE COURSE; ETHNOLOGY; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADULT; BIOPSY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK FACTORS; TIME FACTORS;

EID: 84957061000     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05760515     Document Type: Article

References (43)

1. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS: Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 18: 1353-1361, 2007.
2. Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB: Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol 20: 2065-2074, 2009.
3. Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG: Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol 7: 78-84, 2012.
4. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M; International Diabetic Nephopathy Study Group: The early natural history of nephropathy in Type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54: 2164-2171, 2005.
5. Caramori ML, Parks A, Mauer M: Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 24: 1175-1181, 2013.
6. Gambara V, Mecca G, Remuzzi G, Bertani T: Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol 3:1458-1466, 1993.
7. Østerby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064-1070, 1993.
8. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39: 1569-1576, 1996.
9. Moriya T, Suzuki Y, Inomata S, Iwano M, Kanauchi M, HanedaM: Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes. BMJ Open Diabetes Res Care 2: e000029, 2014.
10. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49: 476-484, 2000.
11. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R, Monga G: Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies. Am J Kidney Dis 39: 713-720, 2002.
12. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L,MeyerTW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342-348, 1997.
13. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Pettitt DJ, Moffett CD, Teutsch SM, Bennett PH: Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31: 730-736, 1988.
14. Nelson RG, Knowler WC, McCance DR, Sievers ML, Pettitt DJ, Charles MA, Hanson RL, Liu QZ, Bennett PH: Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulindependent) diabetes mellitus and proteinuria. Diabetologia 36:1087-1093, 1993.
15. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD; Diabetic Renal Disease Study Group: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 335: 1636-1642, 1996.
16. Pavkov ME, Knowler WC, Hanson RL, Nelson RG: Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians. Curr Diab Rep 8: 486-493, 2008.
17. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518-2531, 2014.
18. Levey AS, Inker LA,Matsushita K, Greene T,Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J: GFR decline as an end point for clinical trials in CKD: A scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64: 821-835, 2014.
19. Weil EJ, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, Lovato T, Richardson M, Myers BD, Nelson RG: Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 82: 1010-1017, 2012.
20. Weil EJ, Fufaa G, Jones LI, Lovato T, Lemley KV, Hanson RL, Knowler WC, Bennett PH, Yee B, Myers BD, Nelson RG: Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetes. Diabetes 62: 3224-3231, 2013.
21. Vasquez B, Flock EV, Savage PJ, Nagulesparan M, Bennion LJ, Baird HR, Bennett PH: Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 26: 127-133, 1984.
22. Chasson AL, Grady HJ, Stanley MA: Determination of creatinine by means of automatic chemical analysis. Tech Bull Regist Med Technol 30: 207-212, 1960.
23. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE: Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 47: 1781-1789, 1995.
24. Weibel ER: Practical Methods for Biological Morphometry, New York, Academic Press, 1979.
25. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155, 1984.
26. Fioretto P, Steffes MW, Mauer M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43: 1358-1364, 1994.
27. Squarer A, Lemley KV, Ambalavanan S, Kristal B, Deen WM, Sibley R, Anderson L, Myers BD: Mechanisms of progressive glomerular injury in membranous nephropathy. J Am Soc Nephrol 9: 1389-1398, 1998.
28. Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM: Indexing glomerular filtration rate for body surface area in obese patients is misleading: Concept and example. Nephrol Dial Transplant 20: 2024-2028, 2005.
29. Pencina MJ, D'Agostino RB: Overall C as a measure of discrimination in survival analysis:Model specific population value and confidence interval estimation. Stat Med 23: 2109-2123, 2004.
30. Demler OV, Pencina MJ, D'Agostino RB Sr.: Misuse of DeLong test to compare AUCs for nested models. Stat Med 31: 2577-2587, 2012.
31. PepeMS, Kerr KF, Longton G,Wang Z: Testing for improvement in prediction model performance. Stat Med 32: 1467-1482, 2013.
32. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS: Comments on integrated discrimination and net reclassification improvements: Practical advice. Stat Med 27: 207-212, 2008.
33. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P: Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 176: 473-481, 2012.
34. Mauer M, Caramori ML, Fioretto P, Najafian B: Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients. NephrolDial Transplant 30: 918-923, 2015.
35. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, De Cosmo S, Viberti G: Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 51:3083-3089, 2002.
36. Steffes MW, Bilous RW, Sutherland DE, Mauer SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41: 679-684, 1992.
37. Ellis EN, Steffes MW, Goetz FC, Sutherland DE, Mauer SM: Glomerular filtration surface in type I diabetes mellitus. Kidney Int 29: 889-894, 1986.
38. Lemley KV, Boothroyd DB, Blouch KL, Nelson RG, Jones LI, Olshen RA, Myers BD: Modeling GFR trajectories in diabetic nephropathy. Am J Physiol Renal Physiol 289: F863-F870, 2005.
39. Hirose K, Tsuchida H, Osterby R, Gundersen HJ: A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfunction. Lab Invest 43: 434-437, 1980.
40. Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA, Hillege HJL, Parving HH, Brenner BM, Shahinfar S, Lambers Heerspink HJ: An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in longterm renal function. Kidney Int 80: 282-287, 2011.
41. Evans M, Bain SC, Hogan S, Bilous RW; Collaborative Study Group participants: Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: Post hoc analysis of the Irbesartan Diabetic Nephropathy Trial. Nephrol Dial Transplant 27: 2255-2263, 2012.
42. Park HW, KimY, KimKH, Jeong HJ, Shin MH, Rozen S, MauerM: Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats. J Renin Angiotensin Aldosterone Syst 8: 110-117, 2007.
43. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR: Adjusting for treatment effects in studies of quantitative traits: Antihypertensive therapy and systolic blood pressure. Stat Med 24: 2911-2935,2005.